Verum Partners LLC Eli Lilly & CO Transaction History
Verum Partners LLC
- $310 Billion
- Q2 2024
A detailed history of Verum Partners LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Verum Partners LLC holds 731 shares of LLY stock, worth $695,890. This represents 0.21% of its overall portfolio holdings.
Number of Shares
731
Previous 720
1.53%
Holding current value
$695,890
Previous $560 Million
18.2%
% of portfolio
0.21%
Previous 0.2%
Shares
6 transactions
Others Institutions Holding LLY
# of Institutions
3,857Shares Held
751MCall Options Held
6.34MPut Options Held
7.97M-
Lilly Endowment Inc Indianapolis, IN97.4MShares$92.7 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA73.9MShares$70.3 Billion1.31% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$62.7 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$48.9 Billion31.1% of portfolio
-
State Street Corp Boston, MA33.9MShares$32.3 Billion1.36% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $905B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...